QTREX Quantum appoints ex-Nano Dimension R&D chief Chappel-Ram as independent director
QTEX•Background and current role
Chappel-Ram is general manager at Digma Medical since January 2025, following earlier senior R&D roles at Edwards Lifesciences and Medinol.
Connection to QTREX acquisition
The board addition follows QTREX’s April 2026 acquisition of Nano Dimension’s AME platform for quantum computing connectivity and RF components.
Independent director appointment
QTREX appointed Dr. Shlomit Chappel-Ram as an independent director, effective July 14, 2026.
She previously served as vice president of R&D at Nano Dimension, leading multidisciplinary AME development programs.
